158 related articles for article (PubMed ID: 4391256)
1. [Effect of alprenolol in the treatment of angina pectoris].
Lippenholtz A; Talmasky S; Berconsky I
Prensa Med Argent; 1969 Sep; 56(27):1357-61. PubMed ID: 4391256
[No Abstract] [Full Text] [Related]
2. Alprenolol in angina pectoris. A clinical and ergometric study with a new beta-adrenergic blocking agent.
Arstila M; Iisalo E; Kallio V
Ann Clin Res; 1969 May; 1(1):13-21. PubMed ID: 4390794
[No Abstract] [Full Text] [Related]
3. [Use of LB-46 in angina pectoris and cardiac arrhythmias].
Maranhão MF; da Cunha GP; Rojas RI
Arq Bras Cardiol; 1972 Feb; 25(1):51-60. PubMed ID: 4403346
[No Abstract] [Full Text] [Related]
4. [Beta-blocking agents in angina pectoris. A double-blind trial].
Aubert AB; Nyberg G; Slaastad R; Tjeldflaat L
Tidsskr Nor Laegeforen; 1970 Feb; 90(4):409-13 passim. PubMed ID: 4393271
[No Abstract] [Full Text] [Related]
5. [New adrenergic blocking agent Visken (LB-46) in the treatment of chronic coronary disease].
Musial W; Tracz W; Krzemińska-Pakula M
Pol Tyg Lek; 1971 May; 26(22):834-6. PubMed ID: 4397439
[No Abstract] [Full Text] [Related]
6. [Treatment of angina pectoris and arrthymias with a beta receptor blockader].
Willems D; Frisch P; Klepzig H
Z Kreislaufforsch; 1971 Apr; 60(4):309-18. PubMed ID: 4397060
[No Abstract] [Full Text] [Related]
7. Human cardiovascular effects of alprenolol, a beta-adrenergic blocker: hemodynamic, antiarrhythmic, and antianginal.
Wasserman AJ; Proctor JD; Allen FJ; Kemp VE
J Clin Pharmacol J New Drugs; 1970; 10(1):37-49. PubMed ID: 4391785
[No Abstract] [Full Text] [Related]
8. Long-term clinical results of oxprenolol in the treatment of cardiac arrhythmias, angina pectoris and hypertrophic subaortic stenosis.
Scebat L; Bensaid J
Postgrad Med J; 1970 Nov; ():Suppl:86-90. PubMed ID: 4395465
[No Abstract] [Full Text] [Related]
9. [Use of a pure beta-blockador, 1-(4-nitrophenyl)-2-isopropylamino-ethanol in angina pectoris].
Gasparotto G; Pagnan A
Folia Cardiol; 1969; 28():40-3. PubMed ID: 4397999
[No Abstract] [Full Text] [Related]
10. [Effectiveness and limitations of adrenergic beta receptor blocking in the treatment of the stenocardia syndrome and of some disorders of cardiac rhythm: clinical trial with INPEA (N-isopropyl-p-mitrophenylethanolamine)].
Piva M; Ongari R; Dotti F
Clin Ter; 1968 Oct; 47(1):53-84. PubMed ID: 4393774
[No Abstract] [Full Text] [Related]
11. A monitored release study. A clinical trial of oxprenolol in general practice.
Forrest WA
Practitioner; 1972 Mar; 208(245):412-6. PubMed ID: 4402044
[No Abstract] [Full Text] [Related]
12. Comparison of the symptomatic, electrocardiographic and haemodynamic effects of acute and long term -blockade in angina pectoris.
Sharma B; Taylor SH
Br J Pharmacol; 1971 Oct; 43(2):470P-471P. PubMed ID: 4400578
[No Abstract] [Full Text] [Related]
13. Prophylactic treatment of angina pectoris. A double-blind cross-over comparison of alprenolol and pentanitrol.
Aubert A; Nyberg G; Slaastad R; Tjeldflaat L
Br Med J; 1970 Jan; 1(5690):203-6. PubMed ID: 4391702
[TBL] [Abstract][Full Text] [Related]
14. [Clinical trial using the beta receptor blockader Visken].
Szám I; Holló J
Med Monatsschr; 1971 Sep; 25(9):425-8. PubMed ID: 4398675
[No Abstract] [Full Text] [Related]
15. Alprenolol treatment of angina pectoris.
Nyberg KG
JAMA; 1972 Apr; 220(1):128. PubMed ID: 5066752
[No Abstract] [Full Text] [Related]
16. Exercise tolerance in patients with angina pectoris. Daily variation and effects of erythrityl tetranitrate, propranolol and alprenolol.
Dagenais GR; Pitt B; Ross RS
Am J Cardiol; 1971 Jul; 28(1):10-6. PubMed ID: 4397511
[No Abstract] [Full Text] [Related]
17. Alprenolol in resuscitation.
Pontinen J; Eggert H; Kemila S
Br Med J; 1971 Dec; 4(5789):723. PubMed ID: 4399701
[No Abstract] [Full Text] [Related]
18. Alprenolol ("aptin") in angina pectoris. A double-blind multicentre trial.
Hickie JB
Med J Aust; 1970 Aug; 2(6):268-72. PubMed ID: 4393977
[No Abstract] [Full Text] [Related]
19. Alprenolol treatment of angina pectoris.
Lyon LJ; Nevins MA
JAMA; 1971 Mar; 215(10):1669. PubMed ID: 4395863
[No Abstract] [Full Text] [Related]
20. [Eraldin: a cardioselective beta-adrenergic receptor blocking agent in the treatment of angina pectoris].
Musial W; Krzemińska-Pakula M; Tracz W
Pol Tyg Lek; 1971 Aug; 26(34):1316-8. PubMed ID: 4398697
[No Abstract] [Full Text] [Related]
[Next] [New Search]
